Anti-SYNGR2 monoclonal antibody

Pre-made anti-SYNGR2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SYNGR2/SYNGR2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1867-Ab-1/ GM-Tg-hg-IP1867-Ab-2Anti-Human SYNGR2 monoclonal antibodyHuman
GM-Tg-rg-IP1867-Ab-1/ GM-Tg-rg-IP1867-Ab-2Anti-Rat SYNGR2 monoclonal antibodyRat
GM-Tg-mg-IP1867-Ab-1/ GM-Tg-mg-IP1867-Ab-2Anti-Mouse SYNGR2 monoclonal antibodyMouse
GM-Tg-cynog-IP1867-Ab-1/ GM-Tg-cynog-IP1867-Ab-2Anti-Cynomolgus/ Rhesus macaque SYNGR2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1867-Ab-1/ GM-Tg-felg-IP1867-Ab-2Anti-Feline SYNGR2 monoclonal antibodyFeline
GM-Tg-cang-IP1867-Ab-1/ GM-Tg-cang-IP1867-Ab-2Anti-Canine SYNGR2 monoclonal antibodyCanine
GM-Tg-bovg-IP1867-Ab-1/ GM-Tg-bovg-IP1867-Ab-2Anti-Bovine SYNGR2 monoclonal antibodyBovine
GM-Tg-equg-IP1867-Ab-1/ GM-Tg-equg-IP1867-Ab-2Anti-Equine SYNGR2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1867-Ab-1/ GM-Tg-hg-IP1867-Ab-2; GM-Tg-rg-IP1867-Ab-1/ GM-Tg-rg-IP1867-Ab-2;
GM-Tg-mg-IP1867-Ab-1/ GM-Tg-mg-IP1867-Ab-2; GM-Tg-cynog-IP1867-Ab-1/ GM-Tg-cynog-IP1867-Ab-2;
GM-Tg-felg-IP1867-Ab-1/ GM-Tg-felg-IP1867-Ab-2; GM-Tg-cang-IP1867-Ab-1/ GM-Tg-cang-IP1867-Ab-2;
GM-Tg-bovg-IP1867-Ab-1/ GM-Tg-bovg-IP1867-Ab-2; GM-Tg-equg-IP1867-Ab-1/ GM-Tg-equg-IP1867-Ab-2
Products NameAnti-SYNGR2 monoclonal antibody
Formatmab
Target NameSYNGR2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SYNGR2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1867-Ag-1Recombinant multi-species SNG2/ SYNGR2 protein


    Target information

    Target IDGM-IP1867
    Target NameSYNGR2
    Gene ID9144,20973,89815,709310,100687829,101080846,513812,100057958
    Gene Symbol and Synonymscellugyrin,Clast2,SYNGR2
    Uniprot AccessionO43760,O54980,A7E3W5
    Uniprot Entry NameSNG2_HUMAN,SNG2_RAT,SNG2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000108639
    Target ClassificationN/A

    The target: SYNGR2, gene name: SYNGR2, also named as . This gene encodes an integral membrane protein containing four transmembrane regions and a C-terminal cytoplasmic tail that is tyrosine phosphorylated. The exact function of this protein is unclear, but studies of a similar rat protein suggest that it may play a role in regulating membrane traffic in non-neuronal cells. The gene belongs to the synaptogyrin gene family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.